Blue Horseshoe Stock: INSE Update & More

Inspired Entertainment Inc. INSE – Update

Yesterday morning, we placed INSE on recovery watch in the wake of its quarterly reporting. We cited the attractive bottom-bounce that was in effect as the markets had tanked the previous day and INSE managed to buck that trend.

Our instincts about this play turned out to be very good, with the stock piling on yet another very solid trading session. The stock’s low came in right at the opening price of 3.86 and it never looked back. INSE ran up to 5.23, representing a respectable single-session rise of 35%

It also closed just three cents lower than the high of day, setting us up to see if the stock can continue to build upon the momentum it has thus far exhibited.


DSW, Inc. DSW

We’d also like to formulate a fresh options idea for the DSW chain, after noticing an attractive chart setup. The stock has been trading at its lowest PPS since May, which when coupled with solid earnings and guidance in this morning’s quarterly report, could make for just the right conditions to strike on some options trades.

We’re going to signal interest in the DSW 12/21 $22.50 & $25 Calls, and keep those on watch throughout the rest of the week and into the next.
_______

Bonus Idea:
SPY Weekly $266.50-268.50 Calls


Extended Watchlist:
CASI, CNAT, HOLX, CDE, TQQQ, TNXP, LCI, AEO(Bottom play)

Blue Horseshoe Stocks: More Thousand Percent Gainers!

Options Review

We included a trio of options ideas in Friday morning’s premarket report, even as we reported hitting a 28-bagger on CGC. Some may have thought that thousand percent gainers were a rarity, but not in this market! They all rose considerably, but TWO out the three ideas yielded chances at single session profits of more than a thousand percent!

Here are those ideas, and the total possible gains they recorded on the day:

AMD Weekly $22.50 & 23 Calls
$22.50: .31-1.48  (+377%) | $23: .07-.97 (+1285%)

ADSK Weekly $147-150 Calls
$147: 6.27-10.58 (+70%) | $148: 3.50-9.59 (+174%) | $149: 3.58-8.40 (+135%) | $150: 2.85-7.62 (+176%)

SPLK Weekly $114-117 Calls
$114: 1.10-12.09 (+999%) | $115: 1.00-11.10 (+1010%) | $116: .95-9.84 (+936%) | $117: 1.10-9.29 (+745%)


Seven Stars Cloud Group Inc SSC

On Friday we noted that our intial alert on SSC on the morning of July 24th led to a a move of 170%+. We then suggested a dip-and-rip could lead to even more gains, and as of the end of the day Thursday we had seen that move, from 2.71 to 4.35.

Friday the rebound continued, with SSC reaching a new high of 5.75. That extended the breadth of this move to 112%, proving that while we mainly focus on options nowadays, our interest in stocks alone still remains.


Extended Watchlist:
NEPT, DPW, RIGL, LLNW, AMRN, BPMX, CNAT, TLRY

Blue Horseshoe Stocks: VSTM, KTOV Recaps & More

Verastem, Inc. VSTM

With impressive new highs being printed yesterday we thought it was a good time to swing back around and recap the recent progress of a stock we’ve been tracking since early this spring. A quick look at the VSTM tag in our archives reveals that we began tracking this play with a mention in our premarket report on March 24th at which time the stock saw a low of 1.59 and never went any lower. That was followed by another reminder just a few weeks ago when the stock was trading in the 2.10′s.

Despite the usual fluctuations, the stock has been in an ascending wedge pattern on the chart from our initial highlight, generally trading in an upward direction and yesterday, hit new highs of 3.75. From our observed low of 1.59 that works out to a total increase of 142%  For those who may have only caught the most recent mention, gains of up to 95% were still attainable as of yesterday’s new high.



Kitov Pharmaceutical Holdings, Inc. KTOV

We included KTOV in yesterday morning’s premarket report after picking it up on our routine morning scan. The stock responded with a very nice daily performance.

From a low of 1.80 it ripped 100% to 2.70 for a perfect double-bagger, and it did so on extreme high volume on the order of 155X the monthly average. With that kind of price action and liquidity, we’ll be certain to keep close tabs on KTOV as we close out this holiday-shortened week.


ProShares Short VIX Short-Term Futures ETF (SVXY) – Options Idea

After some positive jobs numbers went out this morning, we want to signal a range of options in the SVXY, which is one of the funds we use as a market analog. A bullish session for the markets as a whole could spell some nice gain opportunities in the SVXY Weekly $152-154 Calls*.

*We don’t include mentions of weekly options contracts on a Friday without explicitly warning our readers every time. Trading weekly options at the end of the week is a highly risky proposition that should never be attempted by beginning or novice traders! 


Extended Watchlist:
DGLY, GLBS, MARA, AVEO, HTGM, AFSI, CNAT

Blue Horseshoe Stocks: CNAT Recap & More

Conatus Pharmaceuticals, Inc. CNAT

We were fairly confident that at least one of the pharma news plays we put forth in yesterday’s premarket report would turn out a promising session, and CNAT definitely rose to the occasion.

We highlighted it, of course, because of a big collaboration and licensing deal for one of the company’s drugs, which adds a quick $50M cash to the books almost immediately, and even more down the road.

After gapping up considerably in the premarket, the stock underwent a dip-and-rip scenario which carried it to a daily low of 4.27 before it pushed its way up to a high of 5.50. That marked a solid intraday upswing of 29% and came on four times the three-month average volume.


ACADIA Pharmaceuticals, Inc. ACAD

ACAD was the other play off of our pharma watchlist that provided us with significant opportunities, which were even bigger than the previously mentioned stock.

We offered an options idea, the ACAD Weekly $28-31 Calls, and all but a couple sets of contracts in that range produced respectable intraday moves.

$28 Calls – Range: .70-1.66 – Max Gain: 137%
$28.50 Calls – Range: .59-1.40 – Max Gain: 137%
$29 Calls – Range: .40-.80 – Max Gain: 100%
$29.50 Calls – Range: .30-.70 – Max Gain: 133%
$30 Calls – Range: .18-.50 – Max Gain: 178%

______

NIKE, Inc. NKE – Fresh Options Idea

NKE is coming off a post-market earnings beat yesterday, so we want to enter an idea into the logs for this situation.

We’re going to be monitoring the activity in the NKE Weekly $52.50-54 Calls for possible daytrades and/or swing trades into the end of the week.


Extended Watchlist:
LEOM, MMEG, INO, ESEA, SINO, DCIX, DRYS, HIMX(Bottom-Watch)

Blue Horseshoe Stocks: Pharma News Watchlist & More

Pharma News Watchlist:

We’ve got a trio of pharma plays to add to our watchlist on the heels of fresh news releases for each of them this morning. Each stock is gapping up significantly in the premarket, and we’ll be waiting in the wings once the session commences to see if we can use the resulting activity to our advantage.

Akebia Therapeutics, Inc. AKBA – Per the newly announced agreement out today, AKBA has entered into a Collaboration and License Agreement to carry forward with the development of one of its treatments. The deal comes with an immediate payment of $125M, a cash infusion that represents roughly 40% of the company’s total market cap as of yesterday.

______

ACADIA Pharmaceuticals, Inc. ACAD – In the case of ACAD, we’ve gotten word of positive top-line results in a Phase II study it was conducting on the company’s Alzheimer’s drug.  To leverage the present activity to our advantage here, we’re going to track the ACAD Weekly $28-31 Calls. (>>View PR)

_______

Conatus Pharmaceuticals, Inc. CNAT

Here we have another collaboration and licensing deal, for CNAT’s liver drug, which is going to be bringing a $50M cash infusion Conatus’ way. That’s just the initial tranche, with more payments to follow as outlined in the relevant filing (>>View 8-K)


Globalstar, Inc. GSAT

We put GSAT on watch as a possible momentum play in yesterday morning’s premarket report, and while it didn’t break out in a major way, it did continue the trend of solid upward momentum that has been observed in recent sessions. From an early low of 1.25, the stock ran as high as 1.60; a 28% pop.

The performance, while not astronomical, was certainly enough to hold our interest in continuing to monitor GSAT’s activity moving forward.


Cellectar Biosciences, Inc. CLRB – Reminder

We just wanted to take a quick moment to reiterate a possible bottom-play selection we made last week in the form of CLRB. We’re still tracking this one, and think it has a good chance to produce a recovery, possibly following the holiday break. So we’re going to want to leave a space on our watch screens reserved for CLRB in the days and weeks ahead.


Extended Watchlist:
AXPW, CAPS, MFST, ENDV, ETRM, EXAD